SCHEMBL14418340

SCHEMBL14418340

Cc1cc(-c2ccc(/N=N/c3c(N)ccc4cc(S(=O)(=O)O)ccc34)c(C)c2)ccc1N

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SUMO2 P61956 2/20 0.83
▸ SUMO1 P63165 2/20 0.83
▸ SENP7 Q9BQF6 2/20 0.83
▸ SENP2 Q9HC62 2/20 0.83
▸ SENP3 Q9H4L4 1/20 0.83
▸ SENP1 Q9P0U3 1/20 0.83
▸ ENPP2 Q13822 7/20 0.62
▸ MEN1 O00255 3/20 0.59
▸ KMT2A Q03164 3/20 0.59
▸ HTT P42858 1/20 0.59
▸ ALDH1A1 P00352 3/20 0.56
▸ HIF1A Q16665 2/20 0.56
▸ PHLPP2 Q6ZVD8 2/20 0.52
▸ CYP2C9 P11712 5/20 0.50
▸ CYP2C19 P33261 4/20 0.50
▸ HSD17B10 Q99714 4/20 0.50
▸ TSHR P16473 2/20 0.50
▸ THRB P10828 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ TP53 P04637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14413371 0.98 SUMO2 (0.86) SUMO2SUMO1SENP7SENP2SENP3
SCHEMBL4952032 0.98 SUMO2 (0.86) SUMO2SUMO1SENP7SENP2SENP3
SCHEMBL29637786 0.97 SUMO2 (0.84) SUMO2SUMO1SENP7SENP2SENP3
SCHEMBL19132261 0.93 SENP2 (0.78) SUMO2SUMO1SENP7SENP2SENP3
SCHEMBL29374866 0.91 SUMO2 (1.00) SUMO2SUMO1SENP7SENP2SENP3
SCHEMBL14418523 0.91 SUMO2 (1.00) SUMO2SUMO1SENP7SENP2SENP3
SCHEMBL14613567 0.90 SUMO2 (0.74) SUMO2SUMO1SENP7SENP2SENP3
SCHEMBL14418372 0.89 SUMO2 (0.72) SUMO2SUMO1SENP7SENP2SENP3
SCHEMBL12534468 0.86 SUMO2 (0.69) SUMO2SUMO1SENP7SENP2SENP3
SCHEMBL14583209 0.84 SUMO2 (0.67) SUMO2SUMO1SENP7SENP2SENP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7264932-B2 Nuclease inhibitor cocktail APPLERA CORPORATION (US) 2007-09-04 — — US disclosed
US-20070032418-A1 Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same AMBION, INC (US) 2007-02-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032418-A1 Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same RNASE1, RNASEH1, RNASEL SUMO2 3330/4885SUMO1 3284/4885SENP7 1438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback